ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Scientist, Drug Product Formulation Development at CSL - ApplyBlast

Scientist, Drug Product Formulation Development

CSL

1 month ago

Melbourne, Victoria, Australia

Onsite

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Scientist, Drug Product Formulation Development role involves designing, executing, and interpreting formulation development and stability studies for CSL's recombinant product portfolio. This position requires collaborating with cross-functional teams to generate scientific and CMC insights that support clinical development, regulatory submissions, and commercial manufacturing. The role focuses on delivering robust, compliant solutions while driving continuous improvement through innovative technologies and operational excellence.

Responsibilities

Design and execute formulation development and stability studies for recombinant products
Generate critical scientific and CMC insights to support clinical development and regulatory submissions
Lead change controls, process investigations, and validation activities to ensure compliance

Skills

Qualifications

Bachelor or postgraduate qualification in Pharmaceutical Sciences, Chemistry, Biochemistry, Biotechnology, Chemical Engineering or related scientific discipline

About CSL

csl.com

Headquarters

Melbourne, Victoria, Australia

Company Size

10001+ employees

Founded

1916

View Profile

CSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.